While the disparate survival noted above reflects differences across all breast tumors, breast cancer is a heterogeneous disease, including variable expression of estrogen receptor (ER), progesterone receptor (PR) and HER2 proteins. This evidence concerns the gene ESR1 and breast carcinoma.